Former Sandoz executive pleads guilty in U.S. price-fixing probe

A former senior executive at Novartis AG generics unit Sandoz pleaded guilty on Friday for conspiring to fix prices of generic drugs, the latest in a long-running U.S. criminal antitrust probe. Hector Armando Kellum, who was responsible for overseeing generic-drug prices and contracts at Sandoz, a New Jersey-based generic and biosimilar company run by the Swiss pharmaceutical giant, pleaded guilty to conspiring with other drug executives to fix prices from 2013 to 2015.